Novo Nordisk pays $25.8 million to promote its obesity drug
1 year ago

Novo Nordisk pays $25.8 million to promote its obesity drug

Live Mint  

During his address, Dr. Lee Kaplan urged fellow doctors to use their prescription pads to fight the obesity crisis, according to a report by Reuters on December 1. Dr. Kaplan, a leading U.S. weight-loss specialist, recommended turning to new weight-loss medicines like Novo Nordisk's Wegovy to reduce obesity. “We are going to have to use these medications,” he said at the June gathering, “for as long as the body wants to have obesity.” Novo Nordisk's financial ambitions for Wegovy closely align with Kaplan's solution to America's obesity problem. Wegovy and Saxenda, Novo's two obesity drugs, were promoted by U.S. medical professionals at a cost of at least $25.8 million, according to the analysis. The total includes only payments Novo reported it made specifically related to those two drugs; sometimes, it paid obesity specialists far more without mentioning any drugs.

Drugs Obesity Drug Reuters Novo Nordisk Wegovy Novo Kaplan Saxenda Nordisk Pays  obesity  diabetes  promote  according  medical  drug  saxenda  258  nordisk  pays  kaplan  wegovy  drugs  weightloss  novo  million

History of this topic

Eli Lilly new trial is all about the battle to be best weight-loss drug zepbound and wegovy
2 weeks, 5 days ago

Eli Lilly new trial is all about the battle to be best weight-loss drug zepbound and wegovy

India Today  

In a study trial, pharmaceutical giant Eli Lilly's weight-loss drug Zepbound showed better results than another pharmaceutical company, Novo Nordisk's weight-loss drug Wegovy. The trial, called SURMOUNT-5, compared Zepbound to Wegovy, which is a mono GLP-1 receptor agonist in adults living with obesity without diabetes. The results showed Zepbound delivering a remarkable 47% greater relative weight loss compared to Wegovy, …

Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says
2 weeks, 5 days ago

Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study
2 weeks, 6 days ago

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study

Live Mint  

In the first head-to-head test, Eli Lilly’s Zepbound obesity drug helped people lose significantly more weight than its main competitor, Novo Nordisk’s Wegovy. The details People taking Zepbound lost 20.2% of their body weight on average after 72 weeks of treatment in the Lilly- That translated into an average 50-pound loss for people who took Zepbound, while Wegovy users lost …

Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
3 weeks ago

Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms

Live Mint  

* Novo Nordisk India team fears losing competitive edge to Eli Lilly * Novo's Wegovy and Lilly's Mounjaro are GLP-1 receptor agonists * India's obesity rates rising, increasing demand for weight-loss drugs By Leroy Leo and Rishika Sadam BENGALURU/HYDERABAD, Dec 3 - Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of …

Cheap Ozempic? Millions of obese Americans wait on Trump’s decision
3 weeks, 6 days ago

Cheap Ozempic? Millions of obese Americans wait on Trump’s decision

The Independent  

The latest headlines from our reporters across the US sent straight to your inbox each weekday Your briefing on the latest headlines from across the US Your briefing on the latest headlines from across the US SIGN UP I would like to be emailed about offers, events and updates from The Independent. The rule, unveiled on Tuesday by the Health …

Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices
1 month ago

Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices

Salon  

Semaglutide and tirzepatide medications have transformed weight loss, diabetes management, and overall health in recent years. According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market, where more than 180 million people live with obesity. Eli Lilly, Novo Nordisk’s direct competitor and the manufacturer of …

Weight-loss drug Wegovy launched in China
1 month ago

Weight-loss drug Wegovy launched in China

CNN  

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity. Novo gained approval for Wegovy in China in June and will initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug. Strong sales there and in the …

Wegovy/Mounjaro: The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy
Trending News
1 month, 1 week ago

Wegovy/Mounjaro: The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy

CNN  

London CNN — Weight loss drugs such as Wegovy and Ozempic have been hailed worldwide as revolutionary for medicine. British Prime Minister Keir Starmer has said that his government needs to “think differently” about how to reduce pressure on the country’s national health care system, overburdened amid staffing shortages and funding pressures. Tom Little/Reuters The government trial studying links between …

Makers of Wegovy and Ozempic issue warning over deadly weight-loss copycats
Trending News
1 month, 2 weeks ago

Makers of Wegovy and Ozempic issue warning over deadly weight-loss copycats

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Novo Nordisk’s popular weight-loss injection Wegovy and diabetes drug …

Big Pharma’s obesity bonanza faces new tests
1 month, 2 weeks ago

Big Pharma’s obesity bonanza faces new tests

Live Mint  

In terms of recent stock-market frenzies, the Ozempic trade nearly tops the list, second only to speculation that artificial intelligence will soon be writing this column. Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most of those gains flowing to Eli Lilly and Novo Nordisk, the dominant players in the obesity-drug market. …

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage
1 month, 3 weeks ago

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug
54 years, 11 months ago

The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug

Wired  

Drugmaker Novo Nordisk is taking action to curb the massively popular compounded semaglutide industry, which provides copies of its blockbuster weight-loss drugs Ozempic and Wegovy to patients—often for much lower prices. The Danish pharmaceutical company is lobbying the US Food and Drug Administration to add semaglutide to the agency’s Demonstrable Difficulties for Compounding lists, which would block compounding pharmacies from …

Wegovy weight loss: The science and the hype of supplements
2 months, 2 weeks ago

Wegovy weight loss: The science and the hype of supplements

The Hindu  

Published : Oct 04, 2024 18:39 IST - 5 MINS READ It was sometime during the COVID-19 pandemic when Wegovy and Ozempic hit mainstream awareness. When used as a weight loss medication, Wegovy is only recommended “as an adjunct to diet and exercise to reduce weight in patients who are very obese,” Ward told DW. But the side effects mean …

Ozempic and Wegovy can supercharge weight loss and even defy ageing – but can they save the NHS?
3 months, 3 weeks ago

Ozempic and Wegovy can supercharge weight loss and even defy ageing – but can they save the NHS?

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Another piece of research from the same trial suggested …

Eli Lilly is gaining on Novo Nordisk in the obesity race
4 months, 2 weeks ago

Eli Lilly is gaining on Novo Nordisk in the obesity race

Live Mint  

The two companies’ divergent earnings reports this week showed that Indianapolis-based Lilly is moving faster than its Denmark-headquartered counterpart in the race to win the GLP-1 war. Less than a year after approval, Eli Lilly’s weekly prescription volume of Zepbound is about where Novo was with Wegovy volume more than two years in, according to JPMorgan data. And while all …

Wegovy: Ozempic sister drug to be sold in Australia within days
4 months, 3 weeks ago

Wegovy: Ozempic sister drug to be sold in Australia within days

Daily Mail  

A drug that mimics popular weight loss medicine Ozempic will be available in Australian pharmacies within days. Like Ozempic, the drug is administered through a once-weekly pen, however it contains a higher amount of the active ingredient and is used to manage chronic weight conditions, whereas Ozempic is only approved to manage type 2 diabetes. In May the Australian government …

Ozempic-producer Novo Nordisk on track for record spending on lobbying in 2024
4 months, 4 weeks ago

Ozempic-producer Novo Nordisk on track for record spending on lobbying in 2024

Raw Story  

This article originally appeared in OpenSecrets. Novo Nordisk — the pharmaceutical giant behind popular weight-loss drugs Ozempic and Wegovy — spent a record $3.2 million on lobbying in the first six months of 2024 as the Denmark-based company expanded its footprint in the United States. In 2017, after two years of clinical trials, the Food and Drug Administration approved Novo …

Don't insure use of Wegovy slimming drug, health institute says
5 months, 1 week ago

Don't insure use of Wegovy slimming drug, health institute says

Dutch News  

Slimming drug Wegovy should not be included in the basic insurance package because its long-term health benefits are unclear and it will also boost costs, the Dutch healthcare institute has said in recommendations to health minister Fleur Agema. Pharmaceutical company Novo Nordisk filed a request for Wegovy to be admitted to the basic insurance package last year. A majority of …

Don't insure use of Wegovy slimming drug, health institute says
5 months, 1 week ago

Don't insure use of Wegovy slimming drug, health institute says

Dutch News  

Slimming drug Wegovy should not be included in the basic insurance package because its long-term health benefits are unclear and it will also boost costs, the Dutch healthcare institute has said in recommendations to health minister Fleur Agema. Pharmaceutical company Novo Nordisk filed a request for Wegovy to be admitted to the basic insurance package last year. A majority of …

Weight-loss war heats up as Wegovy rival found to lead to faster and greater results
5 months, 2 weeks ago

Weight-loss war heats up as Wegovy rival found to lead to faster and greater results

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please …

Wegovy weight-loss drug OK'd in China
5 months, 4 weeks ago

Wegovy weight-loss drug OK'd in China

China Daily  

FILE PHOTO: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the proportion of overweight and obese adults reached almost 51 percent of the country's 1.4 billion people …

Wegovy weight-loss drug OK'd in China
5 months, 4 weeks ago

Wegovy weight-loss drug OK'd in China

China Daily  

By AI HEPING in New York | chinadaily.com.cn | Updated: 2024-06-26 14:54 FILE PHOTO: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the proportion of overweight and …

Wegovy: At least 25,000 people in the US are starting weight-loss drug each week, drugmaker says
7 months, 3 weeks ago

Wegovy: At least 25,000 people in the US are starting weight-loss drug each week, drugmaker says

CNN  

CNN — Drugmaker Novo Nordisk said it’s been increasing supply of its sought-after weight-loss drug Wegovy, with at least 25,000 people now starting to take the medicine each week in the United States. We’re talking about, many patients, chronic treatment.” Eli Lilly, Novo Nordisk’s biggest competitor, also said this week it expects supply to increase later this year. “While we …

Ozempic, Wegovy: Sanders launches Senate investigation into ‘outrageously high’ pricing of drugs
8 months ago

Ozempic, Wegovy: Sanders launches Senate investigation into ‘outrageously high’ pricing of drugs

CNN  

CNN — Sen. Bernie Sanders is taking aim at the high prices of the blockbuster drugs Ozempic and Wegovy. The Vermont senator, an independent who has long called out drug manufacturers for their costly products, is launching an investigation into the “outrageously high prices” Novo Nordisk charges for the drugs. “Further, if the prices for these products are not substantially …

Medicare can pay for obesity drugs like Wegovy in certain heart patients
9 months ago

Medicare can pay for obesity drugs like Wegovy in certain heart patients

Associated Press  

Medicare can pay for the popular weight-loss drug Wegovy — as long as the patients using it also have heart disease and need to reduce the risk of future heart attacks, strokes and other serious problems, federal officials said Thursday. Part D plans could begin covering the drug “some time this year,” said Tricia Neuman, a Medicare policy specialist at …

Medicare can pay for obesity drugs like Wegovy in certain heart patients
9 months ago

Medicare can pay for obesity drugs like Wegovy in certain heart patients

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Medicare can pay for the …

Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients
9 months, 2 weeks ago

Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients

Associated Press  

The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, federal regulators said Friday. The decision was based on the results of a study that found that Wegovy cut the risk …

Weight-loss drug Wegovy can be marketed for heart benefits after FDA label update
9 months, 2 weeks ago

Weight-loss drug Wegovy can be marketed for heart benefits after FDA label update

CNN  

CNN — Wegovy’s not just for weight loss anymore. The US Food and Drug Administration on Friday approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the medicine’s label, making it the first weight-loss drug to also be cleared to reduce the risk of heart attack, stroke or heart-related death in people at higher risk of these conditions. “Wegovy …

Drugs like Ozempic and Wegovy could boost the US economy by a trillion dollars in a few years, Goldman Sachs predicts
9 months, 3 weeks ago

Drugs like Ozempic and Wegovy could boost the US economy by a trillion dollars in a few years, Goldman Sachs predicts

CNN  

Washington, DC CNN — The US economy is set to reap considerable benefits from Americans taking popular medications used for weight loss, including Ozempic and Wegovy, Goldman Sachs analysts wrote in a recent research report. Goldman Sachs argues that since poor health unambiguously weighs on the economy, improving health outcomes due to GLP-1s could lower costs and boost productivity, shoring …

Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds
1 year, 1 month ago

Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds

Associated Press  

The popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in a large, international study that experts say could change the way doctors treat certain heart patients. “It moves from a kind of therapy that reduces body weight to a therapy that reduces cardiovascular events,” said Dr. Michael Lincoff, the study’s lead author and a heart …

AstraZeneca joins obesity drug craze as it signs £1.6bn deal with Chinese medical group
1 year, 1 month ago

AstraZeneca joins obesity drug craze as it signs £1.6bn deal with Chinese medical group

Daily Mail  

AstraZeneca has entered the race to develop a weight-loss drug after striking a £1.6billion deal with a Chinese medical group. China deal: AstraZeneca boss Pascal Soriot said that the move into weight loss drugs follows 'enormous need around the world' Details emerged just hours after it was revealed that AstraZeneca is facing a multi-million-pound legal battle over claims the efficacy …

How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood
1 year, 3 months ago

How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please …

The obesity drugs waiting to hit the market
1 year, 4 months ago

The obesity drugs waiting to hit the market

The Hindu  

Novo Nordisk said a large study had shown its highly effective obesity drug Wegovy also had a clear cardiovascular benefit, boosting the Danish drugmaker’s hopes of moving beyond Wegovy’s image as a lifestyle drug. The following is a list of companies targeting the next big blockbuster opportunity: Novo Nordisk said a large study had shown its highly effective obesity drug, …

Obesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study
1 year, 4 months ago

Obesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study

Hindustan Times  

Novo Nordisk A/S shares surged to a record after the Danish company’s blockbuster obesity medicine Wegovy reduced the risk of heart attacks and strokes in a highly anticipated study, giving it another potential boost. Obesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study Patients with obesity or overweight and with a history of cardiovascular issues taking …

When will Ozempic pills be available and where? How much will weight loss drug cost?
1 year, 5 months ago

When will Ozempic pills be available and where? How much will weight loss drug cost?

Daily Mail  

Ozempic and Wegovy have become two of the fastest-selling drugs ever, irrevocably changing the obesity treatment landscape - but there have been a couple of catches. Novo Nordisk, the Danish company behind Wegovy and Ozempic, as well as Indiana-based Eli Lilly and New York-based Pfizer, are vying to become the first company to introduce a highly effective, safe, and extremely …

No more needles? A daily pill may work as well as Wegovy shots to treat obesity
1 year, 5 months ago

No more needles? A daily pill may work as well as Wegovy shots to treat obesity

Associated Press  

What if treating obesity could be as easy as popping an effective pill? “If you ask people a random question, ‘Would you rather take a pill or an injection?’ People overwhelmingly prefer a pill,” said Dr. Daniel Bessesen, chief of endocrinology at Denver Health, who treats patients with obesity but was not involved in the new research. Another 16-month study …

FDA warns against using off-brand versions of Ozempic, Wegovy for weight loss
1 year, 6 months ago

FDA warns against using off-brand versions of Ozempic, Wegovy for weight loss

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

FDA warns consumers not to use off-brand versions of Ozempic, Wegovy
1 year, 6 months ago

FDA warns consumers not to use off-brand versions of Ozempic, Wegovy

Associated Press  

The U.S. Food and Drug Administration is warning consumers not to use off-brand versions of the popular weight-loss drugs Ozempic and Wegovy because they might not contain the same ingredients as the prescription products and may not be safe or effective. Agency officials said this week that they have received reports of problems after patients used versions of semaglutide, the …

Rich people are hogging Ozempic, making the drug harder to access for people with diabetes
1 year, 9 months ago

Rich people are hogging Ozempic, making the drug harder to access for people with diabetes

Salon  

The newest Hollywood weight-loss fad isn't a trademarked diet, but a drug called Ozempic. Danish biotech giant Novo Nordisk, which manufactures the drug, said that the company has been experiencing "intermittent supply disruptions on the Ozempic pen" in the United States. He clarified that Ozempic is not a replacement for insulin, and hence patients don't become dependent on it; rather, …

A new class of drugs for weight loss could end obesity
1 year, 9 months ago

A new class of drugs for weight loss could end obesity

Live Mint  

How did Kim Kardashian, a reality tv star, lose enough weight to fit into a slinky dress once worn by Marilyn Monroe? Fatima Stanford, who studies obesity at Massachusetts General Hospital and Harvard Medical School, notes that attempts to lose weight through diet and exercise work for only 10-20% of the population: “For most people we don’t see a dramatic …

Maker of fat-loss drugs Wegovy and Ozempic says shortages will be fixed in weeks
1 year, 10 months ago

Maker of fat-loss drugs Wegovy and Ozempic says shortages will be fixed in weeks

Daily Mail  

The maker of pharmaceutical blockbuster Wegovy for weight loss expects shortages to be resolved in the next few months as it ramps up production. An increase in demand combined with manufacturing hiccups caused a contraction in the supply chain last year, leaving behind a shortage of both Wegovy and its sister drug Ozempic. There has been such high demand that …

Doctors Reveal What They Really Think Of Weight Loss Drugs Like Ozempic
1 year, 10 months ago

Doctors Reveal What They Really Think Of Weight Loss Drugs Like Ozempic

Huff Post  

LOADING ERROR LOADING A new class of weight loss drugs on the market have been making waves since they were authorized as a treatment for obesity in 2021. The prescription injections were introduced as a diabetes treatment in 2017, but people soon realized that the medications — which help people with diabetes to manage their blood sugar levels — also …

Americans are buying raw Ozempic and Wegovy chemicals online from shady bodybuilding websites
1 year, 11 months ago

Americans are buying raw Ozempic and Wegovy chemicals online from shady bodybuilding websites

Daily Mail  

Doctors are warning against a 'dangerous' trend of Americans making DIY weight-loss injections at home with raw chemicals bought online. People are being driven to websites normally used by research groups to buy experimental chemicals amid a nationwide shortage of Wegovy and Ozempic. Some websites state the product should only be used for 'laboratory and research use only' but customer …

Khloe Kardashian slams claims she used diabetes drug for weight loss
1 year, 11 months ago

Khloe Kardashian slams claims she used diabetes drug for weight loss

Daily Mail  

Khloe Kardashian has hit back at claims she uses a controversial diabetes medication to lose weight. Clapping back: Khloe Kardashian has hit back at claims she uses a controversial diabetes medication to lose weight The mother-of-two showcased her incredible abs in an Instagram post on Tuesday as she posed for Sorbet magazine - prompting one fan to claim it was …

Novo Nordisk Statement to 60 Minutes
1 year, 11 months ago

Novo Nordisk Statement to 60 Minutes

CBS News  

Promising new weight loss medication in short supply and often not covered by insurance | 60 Minutes Prior to 60 Minutes', January 1, 2023, broadcast which featured correspondent Lesley Stahl's story on obesity, we reached out to Novo Nordisk, the maker of Wegovy and Ozempic about recent shortages of the medications. The company told 60 Minutes the following: Ozempic The …

Doctors explain how Wegovy and Ozempic work
1 year, 11 months ago

Doctors explain how Wegovy and Ozempic work

CBS News  

Anti-obesity drugs are growing in popularity in the United States as a greater number of Americans are being diagnosed with obesity than ever before. In the video above, Dr. Caroline Apovian, a weight management specialist at Brigham and Women's Hospital in Boston, who consults for Novo Nordisk, explains how the medications work. While reporting this story, 60 Minutes learned that …

Wegovy, Ozempic. Everything you need to know about 'game-changer' weight loss shots
2 years, 1 month ago

Wegovy, Ozempic. Everything you need to know about 'game-changer' weight loss shots

Daily Mail  

Wegovy has taken the world by storm since it first arrived on the market last year, with everyone from doctors, celebrities and patients singing its praises. The weekly shot is the most effective weight loss medication on the market, with users dropping 15 per cent of their body weight over 68 weeks in clinical trials. Tech mogul Elon Musk claimed …

FDA approves obesity drug that helped people cut weight 15%
3 years, 6 months ago

FDA approves obesity drug that helped people cut weight 15%

Associated Press  

Regulators on Friday said a new version of a popular diabetes medicine could be sold as a weight-loss drug in the U.S. The Food and Drug Administration approved Wegovy, a higher-dose version of Novo Nordisk’s diabetes drug semaglutide, for long-term weight management. “With existing drugs, you’re going to get maybe 5% to 10% weight reduction, sometimes not even that,” said …

FDA approves obesity drug that helped people cut weight 15%
3 years, 6 months ago

FDA approves obesity drug that helped people cut weight 15%

LA Times  

A package of injection pens for Wegovy, a diabetes medicine that can now be sold as a weight-loss drug in the U.S. Regulators on Friday said a new version of a popular diabetes medicine could be sold as a weight-loss drug in the U.S. The Food and Drug Administration approved Wegovy, a higher-dose version of Novo Nordisk’s diabetes drug semaglutide, …

Discover Related